Anna Yukhananov – Page 11

J&J to stop selling controversial vaginal implants

August 23, 2021 at 8:51 a.m.

WASHINGTON/NEW YORK (Reuters) - Johnson & Johnson said it would stop selling vaginal mesh implants after a raft of lawsuits about the devices causing complications such as infection. The diversified...

J&J to stop selling controversial vaginal implants

December 24, 2018 at 6:11 a.m.

WASHINGTON/NEW YORK (Reuters) - Johnson & Johnson said it would stop selling vaginal mesh implants after a raft of lawsuits about the devices causing complications such as infection. The diversified...

U.S. FDA checks dictionary on corn syrup vs sugar

May 13, 2019 at 6:31 p.m.

WASHINGTON (Reuters) - U.S. food and beverage makers who add high-fructose corn syrup to soda, breakfast cereal and other items will not be able to label it "corn sugar," under...

FDA warns J&J unit about tampon complaints

May 13, 2019 at 6:27 p.m.

WASHINGTON (Reuters) - U.S. drug regulators chided a Johnson & Johnson unit for not reporting or investigating customer complaints about O.B. Tampons or personal lubricants similar to K-Y Jelly. The...

U.S. Senate passes bipartisan FDA funding bill

August 23, 2021 at 7:44 a.m.

WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration, a regulatory powerhouse with sweeping influence over...

U.S. Senate passes bipartisan FDA funding bill

May 13, 2019 at 6:21 p.m.

WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration, a regulatory powerhouse with sweeping influence over...

U.S. advisers reject J&J/Bayer’s Xarelto for acute coronary patients

August 23, 2021 at 7:34 a.m.

SILVER SPRING, Maryland (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks...

U.S. advisers reject J&J/Bayer’s Xarelto for acute coronary patients

May 13, 2019 at 6:18 p.m.

SILVER SPRING, Maryland (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks...

FDA staff sends mixed message on J&J drug Xarelto

August 23, 2021 at 7:20 a.m.

WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson & Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart...

FDA staff sends mixed message on J&J drug Xarelto

May 13, 2019 at 6:14 p.m.

WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson & Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart...

All Stories